Tag: evolocumab
EBBINGHAUS trial shows non-inferiority of evolocumab for cognitive function in cardiovascular group
Amgen has announced d...
ACC 2017: PCSK9 inhibitor evolocumab significantly reduces the risk of cardiovascular events
Data for a new drug t...
